10-277343-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_014974.3(DIP2C):āc.4653T>Cā(p.Tyr1551Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.266 in 1,613,930 control chromosomes in the GnomAD database, including 58,175 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.27 ( 5667 hom., cov: 32)
Exomes š: 0.27 ( 52508 hom. )
Consequence
DIP2C
NM_014974.3 synonymous
NM_014974.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.124
Genes affected
DIP2C (HGNC:29150): (disco interacting protein 2 homolog C) This gene encodes a member of the disco-interacting protein homolog 2 family. The protein shares strong similarity with a Drosophila protein which interacts with the transcription factor disco and is expressed in the nervous system. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 10-277343-A-G is Benign according to our data. Variant chr10-277343-A-G is described in ClinVar as [Benign]. Clinvar id is 1598742.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.124 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.329 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DIP2C | NM_014974.3 | c.4653T>C | p.Tyr1551Tyr | synonymous_variant | 37/37 | ENST00000280886.12 | NP_055789.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DIP2C | ENST00000280886.12 | c.4653T>C | p.Tyr1551Tyr | synonymous_variant | 37/37 | 1 | NM_014974.3 | ENSP00000280886.6 | ||
DIP2C | ENST00000634311.1 | c.4851T>C | p.Tyr1617Tyr | synonymous_variant | 39/39 | 5 | ENSP00000489203.1 |
Frequencies
GnomAD3 genomes AF: 0.271 AC: 41183AN: 152026Hom.: 5657 Cov.: 32
GnomAD3 genomes
AF:
AC:
41183
AN:
152026
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.265 AC: 66612AN: 251334Hom.: 9246 AF XY: 0.273 AC XY: 37127AN XY: 135856
GnomAD3 exomes
AF:
AC:
66612
AN:
251334
Hom.:
AF XY:
AC XY:
37127
AN XY:
135856
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.265 AC: 388057AN: 1461786Hom.: 52508 Cov.: 34 AF XY: 0.269 AC XY: 195913AN XY: 727196
GnomAD4 exome
AF:
AC:
388057
AN:
1461786
Hom.:
Cov.:
34
AF XY:
AC XY:
195913
AN XY:
727196
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.271 AC: 41199AN: 152144Hom.: 5667 Cov.: 32 AF XY: 0.272 AC XY: 20255AN XY: 74390
GnomAD4 genome
AF:
AC:
41199
AN:
152144
Hom.:
Cov.:
32
AF XY:
AC XY:
20255
AN XY:
74390
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1027
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
DIP2C-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 21, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at